New technique maps genetic variants driving neurodegenerative disease risk
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Dec-2025 06:11 ET (21-Dec-2025 11:11 GMT/UTC)
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in post-menopausal women with obesity. It also raises the possibility that treatment of these aggressive breast cancers could be improved with addition of weight-loss drugs known as GLP-1 receptor agonists.